Sunny Pharmtech Inc.

Sunny Pharmtech Inc.verified

6676.TWO

Price:

$14.1

Market Cap:

$2.10B

Sunny Pharmtech Inc. engages in the research, development, production, and sale of drug substances and products, and active pharmaceutical ingredients in Taiwan and internationally. Its products portfolio include lidocaine ointment that can be used as an anesthetic lubricant for intubation, which temporarily relieves pain associated with minor burns, sunburn, skin abrasions, and insect bites; cyanocobalamin injection for use in vitamin B12 deficiency and pernicious anemia caused by malabsorption; nitrofurantoin capsules for urinary tract infection; aminocaproic acid tablets for blood diseases, as well as for hyper-proteolytic enzymes; and carboprost tromethamine injection for therapeutic abo...[Read more]

Industry

Biotechnology

IPO Date

2022-01-19

Stock Exchange

TWO

Ticker

6676.TWO

The PE Ratio as of December 2025 (TTM) for Sunny Pharmtech Inc. (6676.TWO) is -7.75

According to Sunny Pharmtech Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -7.75. This represents a change of -78.90% compared to the average of -36.72 of the last 4 quarters.

Sunny Pharmtech Inc. (6676.TWO) Historical PE Ratio (quarterly & annually)

How has 6676.TWO PE Ratio performed in the past?

The mean historical PE Ratio of Sunny Pharmtech Inc. over the last ten years is -28.71. The current -7.75 PE Ratio has changed 2.60% with respect to the historical average. Over the past ten years (40 quarters), 6676.TWO's PE Ratio was at its highest in in the June 2025 quarter at -3.40. The PE Ratio was at its lowest in in the December 2023 quarter at -111.79.

Quarterly (TTM)
Annual

Average

-28.71

Median

-19.14

Minimum

-77.39

Maximum

-12.50

Sunny Pharmtech Inc. (6676.TWO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Sunny Pharmtech Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 394.05%

Maximum Annual PE Ratio = -12.50

Minimum Annual Increase = -72.71%

Minimum Annual PE Ratio = -77.39

Quarterly (TTM)
Annual
YearPE RatioChange
2024-21.12-72.71%
2023-77.39394.05%
2022-15.66-8.78%
2021-17.17-39.57%
2020-28.41127.25%

Sunny Pharmtech Inc. (6676.TWO) Average PE Ratio

How has 6676.TWO PE Ratio performed in the past?

The current PE Ratio of Sunny Pharmtech Inc. (6676.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-38.06

5-year avg

-31.95

10-year avg

-28.71

Sunny Pharmtech Inc. (6676.TWO) PE Ratio vs. Peers

How is 6676.TWO’s PE Ratio compared to its peers?

Sunny Pharmtech Inc.’s PE Ratio is greater than Genomics BioSci & Tech. Co.,Ltd. (-10.47), greater than Chunghwa Chemical Synthesis & Biotech Co., Ltd. (-20.23), greater than Advagene Biopharma Co., Ltd. (-24.47), less than Greenyn Biotechnology Co., Ltd (14.41), greater than Hcmed (-12.59), greater than GlycoNex Incorporation (-11.61), less than MegaPro Biomedical Co., Ltd (-5.47), less than Enimmune corporation (-6.82), less than Intech Biopharm Corporation (-6.72), greater than Meribank Biotech Co., Ltd (-22.84),

Build a custom stock screener for Sunny Pharmtech Inc. (6676.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sunny Pharmtech Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sunny Pharmtech Inc. (6676.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sunny Pharmtech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Sunny Pharmtech Inc.'s PE Ratio?

How is the PE Ratio calculated for Sunny Pharmtech Inc. (6676.TWO)?

What is the highest PE Ratio for Sunny Pharmtech Inc. (6676.TWO)?

What is the 3-year average PE Ratio for Sunny Pharmtech Inc. (6676.TWO)?

What is the 5-year average PE Ratio for Sunny Pharmtech Inc. (6676.TWO)?

How does the current PE Ratio for Sunny Pharmtech Inc. (6676.TWO) compare to its historical average?